193 related articles for article (PubMed ID: 18951242)
1. Re-evaluation of the fludrocortisone test: duration, NaCl supplementation and cut-off limits for aldosterone.
Westerdahl C; Bergenfelz A; Larsson J; Nerbrand C; Valdemarsson S; Wihl A; Isaksson A
Scand J Clin Lab Invest; 2009; 69(2):234-41. PubMed ID: 18951242
[TBL] [Abstract][Full Text] [Related]
2. High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.
Westerdahl C; Bergenfelz A; Isaksson A; Wihl A; Nerbrand C; Valdemarsson S
Scand J Prim Health Care; 2006 Sep; 24(3):154-9. PubMed ID: 16923624
[TBL] [Abstract][Full Text] [Related]
3. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the saline infusion test and the fludrocortisone suppression test for the diagnosis of primary aldosteronism.
Willenberg HS; Vonend O; Schott M; Gao X; Blondin D; Saleh A; Rump LC; Scherbaum WA
Horm Metab Res; 2012 Jun; 44(7):527-32. PubMed ID: 22689209
[TBL] [Abstract][Full Text] [Related]
5. Plasma aldosterone to renin ratio predicts treatment response in primary aldosteronism: is volume loading needed?
Juutilainen AM; Voutilainen ET; Mykkänen L; Niskanen L
Blood Press; 2005; 14(4):245-50. PubMed ID: 16126559
[TBL] [Abstract][Full Text] [Related]
6. Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.
Giacchetti G; Ronconi V; Lucarelli G; Boscaro M; Mantero F
J Hypertens; 2006 Apr; 24(4):737-45. PubMed ID: 16531803
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.
Rossi GP; Belfiore A; Bernini G; Desideri G; Fabris B; Ferri C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Montemurro D; Palumbo G; Rizzoni D; Rossi E; Semplicini A; Agabiti-Rosei E; Pessina AC; Mantero F;
J Hypertens; 2007 Jul; 25(7):1433-42. PubMed ID: 17563566
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of autonomous aldosterone secretion among patients with essential hypertension.
Gouli A; Kaltsas G; Tzonou A; Markou A; Androulakis II; Ragkou D; Vamvakidis K; Zografos G; Kontogeorgos G; Chrousos GP; Piaditis G
Eur J Clin Invest; 2011 Nov; 41(11):1227-36. PubMed ID: 21534948
[TBL] [Abstract][Full Text] [Related]
9. Comparison of confirmatory tests for the diagnosis of primary aldosteronism.
Mulatero P; Milan A; Fallo F; Regolisti G; Pizzolo F; Fardella C; Mosso L; Marafetti L; Veglio F; Maccario M
J Clin Endocrinol Metab; 2006 Jul; 91(7):2618-23. PubMed ID: 16670162
[TBL] [Abstract][Full Text] [Related]
10. Seated saline suppression testing for the diagnosis of primary aldosteronism: a preliminary study.
Ahmed AH; Cowley D; Wolley M; Gordon RD; Xu S; Taylor PJ; Stowasser M
J Clin Endocrinol Metab; 2014 Aug; 99(8):2745-53. PubMed ID: 24762111
[TBL] [Abstract][Full Text] [Related]
11. Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism.
Pizzolo F; Raffaelli R; Memmo A; Chiecchi L; Pavan C; Guarini P; Guidi GC; Franchi M; Corrocher R; Olivieri O
J Hypertens; 2010 Jan; 28(1):135-42. PubMed ID: 19952782
[TBL] [Abstract][Full Text] [Related]
12. Establishment of reference values for endocrine tests. III: Primary aldosteronism.
Baas SJ; Endert E; Fliers E; Prummel MF; Wiersinga WM
Neth J Med; 2003 Feb; 61(2):37-43. PubMed ID: 12735419
[TBL] [Abstract][Full Text] [Related]
13. The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism.
Willenberg HS; Kolentini C; Quinkler M; Cupisti K; Krausch M; Schott M; Scherbaum WA
Eur J Clin Invest; 2009 Jan; 39(1):43-50. PubMed ID: 19067735
[TBL] [Abstract][Full Text] [Related]
14. [The aldosterone to Renin ratio in secondary hypertension].
Seiler L; Reincke M
Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
[TBL] [Abstract][Full Text] [Related]
15. [New index of using serum sodium and potassium and urine sodium and potassium jointly in screening primary aldosteronism in hypertensive patients].
Yin GS; Zhang SL; Yan L; Li F; Qi YQ; Chen ZC; Cheng H
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):962-6. PubMed ID: 20646645
[TBL] [Abstract][Full Text] [Related]
16. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
[TBL] [Abstract][Full Text] [Related]
18. Captopril suppression: limitations for confirmation of primary aldosteronism.
Westerdahl C; Bergenfelz A; Isaksson A; Valdemarsson S
J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):326-32. PubMed ID: 21273222
[TBL] [Abstract][Full Text] [Related]
19. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone LC-MS/MS Assay-Specific Threshold Values in Screening and Confirmatory Testing for Primary Aldosteronism.
Guo Z; Poglitsch M; McWhinney BC; Ungerer JPJ; Ahmed AH; Gordon RD; Wolley M; Stowasser M
J Clin Endocrinol Metab; 2018 Nov; 103(11):3965-3973. PubMed ID: 30137438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
